PADI2 and glioblastoma: In GBM in vitro models, PAD2, 3, and 4 isozyme expression was shown to differ between GBM cell lines [15], which correlated to different effectivity of the PAD isozyme-specific inhibitors on invasion properties and EV signature modulation [17].